Legal sources with official primary sources

Printed ·

SMLM Previewerrors, bugs and incomplete coverage may occurThe model is production-ready during Q4-26

Skip to main content
Skip to the answer

Back to the decisions

Court of Justice of the European Union · Judgment

C‑310/13Novo Nordisk Pharma GmbH v S

Decided
2014-11-20
ECLI
ECLI:EU:C:2014:2385
CELEX
62013CJ0310
Finality
Final, the decision cannot be appealed

Also searched as: C-310/13, Case C-310/13, C-310/13 2014, ECLI:EU:C:2014:2385.

The court's own keywords

Reference for a preliminary ruling — Directive 85/374/EEC — Consumer protection — Liability for defective products — Material scope of the directive — Special liability system existing on the date of notification of that directive — Permissibility of a national liability system enabling information on the adverse effects of pharmaceutical products to be obtained.

Interprets

Core objects in the machine route

Summary: Final, the decision cannot be appealed

This page shows the judgment and its core data. Risk assessment, relations, changes, agent answers with reasoning and provenance are open without a key in the machine route.

Source: NovaCopilot

Node map: relations between precedents

How the judgment has been affected over time, read from the judgments' own text. Every step has paragraph and hash in the machine route.

Reading relations …

Source: NovaCopilot

NovaCopilot reasons out a short answer from statutes and case law, with the source right below. 5 answers a day are free.

NovaCopilot reasons: a short answer of at most 75 words, built only on our register, with the source right below.

Source: NovaCopilot

Get official document

Retrieved directly from EUR-Lex when you click. No permanent storage on our side. How it works

Machine addresses

id
eu:c-310-13

Read from EU:s publikationsbyrå, Cellar (EUR-Lex och CURIA) on 2026-08-22.

The row repeats what the source states. It is not a summary, not a conclusion about any single case and not legal advice.

Verifiable trust signals

  • Source-linked answers and explicit evidence gaps
  • Obligations, controls, risks and consequences
  • Stable objects and verifiable checksums
  • Rule-based objects, optional source-linked reasoning
  • Model card, source status and audit

Model cardAudit